Skip to Main Content
Contribute Try STAT+ Today

Telehealth startup Ro is expanding its partnership with pharma giant Pfizer’s generics arm to offer its generic versions of commonly prescribed blood pressure and cholesterol medications. 

Through its virtual mail-order pharmacy, Ro will supply Pfizer-produced generics of Lipitor, a cholesterol drug, and Norvasc, a hypertension medication.  The medications will be made available through Ro’s $5-per-month prescription drug service, which launched earlier this year and which doesn’t take insurance. 

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.